semaglutide causing depression The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy Beyond Diabetes: Semaglutide's Role in
Description
What does clinical evidence say about GLP-1 medications and lymphedema
Diabetes itself increases NAION risk, creating particularly dangerous situations when patients take GLP-1 medications that multiply already elevated baseline risk
Some include peer practice, live Q&A, and mentor support
Reduced food intake means less water from food (which normally contributes 20% of daily fluid intake)
however, it did not reach statistical significance
